Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Phase 1 Trial of CD30-Directed, CCR4 Co-Expressing Chimeric Antigen Receptor T-Cells in Patients with CD30 + Cutaneous T-Cell Lymphomas Refractory to Brentuximab Vedotin

Daniel K Reef, Catherine Joyce Arago Cheng, Caroline Babinec, Kelly Hoye, John West, J. Kaitlin Morrison, Faith Brianne Buchanan, Ashley Zanter, Angela Denise Spruill, Kimberly A. Kasow, Anastasia Ivanova, Edith Bowers, Jonathan Serody, Barbara Savoldo, Gianpietro Dotti, Natalie Grover, Anne W Beaven

Blood (2024) 144 (Supplement 1): 3468.

https://doi.org/10.1182/blood-2024-201799

Published: 2024

Journal Articles

Long Term Outcomes of a Randomized Trial of Anti-T Lymphocyte Globulin to Improve Moderate-Severe Chronic Gvhd Free Survival after Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Analysis

Blood (2024) 144 (Supplement 1): 4911.

https://doi.org/10.1182/blood-2024-205572

Published: 2024

Journal Articles

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

Natalie Grover, Dominic Moore, Anastasia Ivanova, Anne W Beaven, Christopher Dittus, Catherine Joyce Arago Cheng, Kelly Hoye, Caroline Babinec, Faith Brianne Buchanan, Angela Denise Spruill, Ashley Zanter, John West, J. Kaitlin Morrison, Paul Armistead, Kimberly A. Kasow, Jonathan Serody, Gianpietro Dotti, Barbara Savoldo

Blood (2024) 144 (Supplement 1): 919.

https://doi.org/10.1182/blood-2024-200932

Published: 2024

Journal Articles

IL-33 Induces Paneth Cell Production of EGF and Soluble ST2, Regulating Epithelial Regeneration after Intestinal Injury

Marco Calafiore, YA-Yuan Fu, Paola Vinci, Viktor Arnhold, Winston Chang, Suze Jansen, Anastasiya Egorova, Shuichiro Takashima, Jason Kuttiyara, Takahiro Ito, Jonathan Serody, Susumu Nakae, Heth Turnquist, Johan van Es, Hans Clevers, Caroline A. Lindemans, Bruce R Blazar, Alan M. Hanash

Blood (2023) 142 (Supplement 1): 346.

https://doi.org/10.1182/blood-2023-191189

Published: 2023

Journal Articles

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Matthew C. Foster, Barbara Savoldo, Winnie Lau, Clio Rubinos, Natalie Grover, Paul Armistead, James Coghill, Robert S. Hagan, Kaitlin Morrison, Faith Brianne Buchanan, Catherine Cheng, Spencer Laing, Anastasia Ivanova, John West, Aaron Foster, Jonathan Serody, Gianpietro Dotti

Blood (2021) 137 (23): 3306–3309.

https://doi.org/10.1182/blood.2021010784

Published: 2021

Includes: Supplemental data

Journal Articles

Pathogenic Bhlhe40 + GM-CSF + CD4 + T cells promote indirect alloantigen presentation in the GI tract during GVHD

Clint Piper, Vivian Zhou, Richard Komorowski, Aniko Szabo, Benjamin Vincent, Jonathan Serody, Maria-Luisa Alegre, Brian T. Edelson, Reshma Taneja, William R. Drobyski

Blood (2020) 135 (8): 568–581.

https://doi.org/10.1182/blood.2019001696

Published: 2020

Includes: Supplemental data

Journal Articles

GVHD and miR: good things in small packages

Jonathan Serody

Blood (2015) 126 (11): 1265–1267.

https://doi.org/10.1182/blood-2015-07-657114

Published: 2015

Journal Articles

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

Mathew Meeneghan, MD, Anna Snavely, PhD, Abbie Smith-Ryan, PhD, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Ethan Basch, MD MSc, Antonia Bennett, PhD, Charlotte Shatten, MA, Brett Phillips, BS, Jonathan Serody, MD, PhD, Don A. Gabriel, MD PhD, Katarzyna Joanna Jamieson, MD, James Coghill, MD, Paul M. Armistead, MD PhD, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2014) 124 (21): 2611.

https://doi.org/10.1182/blood.V124.21.2611.2611

Published: 2014

Journal Articles

High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd

Prasanthi V. Tata, MS, Benjamin G. Vincent, MD, Pei-Fen Kuan, PhD, Corbin Jones, PhD, Jonathan Serody, MD, Stefanie Sarantopoulos, MD, PhD

Blood (2013) 122 (21): 2055.

https://doi.org/10.1182/blood.V122.21.2055.2055

Published: 2013

Journal Articles

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Hemamalini Bommiasamy, Ph.D., Laura Ott, Ph.D., Shelly West, B.S., LeShara M Fulton, Ph.D., Angela Panoskaltsis-Mortari, Bruce R Blazar, MD, Lynette Fouser, PhD, Jonathan Serody, MD

Blood (2013) 122 (21): 4482.

https://doi.org/10.1182/blood.V122.21.4482.4482

Published: 2013

Journal Articles

Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models

Kaifeng Lisa Lin, PhD, LeShara M Fulton, Ph.D., Jonathan Serody, MD

Blood (2013) 122 (21): 4477.

https://doi.org/10.1182/blood.V122.21.4477.4477

Published: 2013

Journal Articles

Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model

Blood (2013) 122 (21): 292.

https://doi.org/10.1182/blood.V122.21.292.292

Published: 2013

Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Blood (2013) 122 (21): 910.

https://doi.org/10.1182/blood.V122.21.910.910

Published: 2013

Journal Articles

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Blood (2012) 120 (12): 2529–2536.

https://doi.org/10.1182/blood-2012-06-438911

Published: 2012

Journal Articles

Bacterial sepsis and GI tract GVHD: more commensal than you think

Jonathan Serody

Blood (2012) 120 (1): 6–7.

https://doi.org/10.1182/blood-2012-05-427435

Published: 2012

Journal Articles

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

William A Wood, MD, MPH, Julia Whitley, BS, Ravi K Goyal, Paul M Brown, PhD, Andrew Sharf, Robert N Irons, PA, Kamakshi Rao, PharmD, Amber N Essenmacher, PA, Jonathan Serody, MD, James Coghill, MD, Paul M. Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Thomas C. Shea, MD

Blood (2011) 118 (21): 2083.

https://doi.org/10.1182/blood.V118.21.2083.2083

Published: 2011

Journal Articles

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Thomas C. Shea, MD, Christine Walko, PharmD, Anastasia Ivanova, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, FRCPC, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, William A. Wood, MD, MPH, Jonathan Serody, MD

Blood (2011) 118 (21): 1940.

https://doi.org/10.1182/blood.V118.21.1940.1940

Published: 2011

Journal Articles

Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells

Hendrik W. Van Deventer, MD, MS, Robert Mango, Jonathan Serody, MD

Blood (2010) 116 (21): 1372.

https://doi.org/10.1182/blood.V116.21.1372.1372

Published: 2010

Journal Articles

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

LeShara M Fulton, BA, Michael J Carlson, PhD, James Coghill, MD, Michelle L. West, BS, Angela Panoskaltisis-Mortari, PhD, Bruce R. Blazar, MD, Dan Littman, PhD, Jonathan Serody, MD

Blood (2010) 116 (21): 3742.

https://doi.org/10.1182/blood.V116.21.3742.3742

Published: 2010

Journal Articles

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Don A. Gabriel, MD, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Charles van der Horst, MD, Jonathan Serody, MD, James Coghill, MD, Stefanie Sarantopoulos, MD, PhD, Paul Armistead, MD, PhD, William Wood, MD, MPH, Thomas C. Shea, MD

Blood (2010) 116 (21): 4550.

https://doi.org/10.1182/blood.V116.21.4550.4550

Published: 2010

NARROW

Phase 1 Trial of CD30-Directed, CCR4 Co-Expressing Chimeric Antigen Receptor T-Cells in Patients with CD30 + Cutaneous T-Cell Lymphomas Refractory to Brentuximab Vedotin

Long Term Outcomes of a Randomized Trial of Anti-T Lymphocyte Globulin to Improve Moderate-Severe Chronic Gvhd Free Survival after Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Analysis

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

IL-33 Induces Paneth Cell Production of EGF and Soluble ST2, Regulating Epithelial Regeneration after Intestinal Injury

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Pathogenic Bhlhe40 + GM-CSF + CD4 + T cells promote indirect alloantigen presentation in the GI tract during GVHD

GVHD and miR: good things in small packages

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models

Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

Bacterial sepsis and GI tract GVHD: more commensal than you think

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only